hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06357104, orgStudyIdInfo id: SCI-CT-0001, briefTitle: Detoxification From the Lipid Tract, statusModule overallStatus: COMPLETED, startDateStruct date: 2024-02-26, primaryCompletionDateStruct date: 2024-03-14, completionDateStruct date: 2024-03-20, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Pachankis, Yang I., M.D., class: INDIV, collaborators name: First Affiliated Hospital of Chongqing Medical University, descriptionModule briefSummary: Apart from electroencephalogram biofeedback and electrical brain stimulation adopted for maintenance treatment, the study utilizes ultra-low frequency transcranial magnetic stimulation (ULF-TMS) for initial γ-aminobutyric acid (GABA) stimulation. The cocktail therapy starts after the primary efficacy endpoint, and concomitant therapy is adopted throughout the study., conditionsModule conditions: COVID-19 Vaccine Adverse Reaction, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 1, type: ACTUAL, armsInterventionsModule interventions name: electroencephalogram biofeedback, interventions name: electrical brain stimulation, interventions name: ultra-low frequency transcranial magnetic stimulation, interventions name: Sertraline Hydrochloride, interventions name: Clonazepam, interventions name: Alprazolam, interventions name: Metoprolol, interventions name: Olanzapine, interventions name: Pravastatin Sodium 20 MG, interventions name: Sacubitril Valsartan Sodium Hydrate, outcomesModule primaryOutcomes measure: Changes in Leukocyte and Components' Quantities, primaryOutcomes measure: Changes in Leukocyte Components' Ratios, primaryOutcomes measure: Quantity Changes in Megakaryocyte-Erythroid Progenitor, primaryOutcomes measure: Changes in Hemoglobin Distribution, primaryOutcomes measure: Changes in Mean Corpuscular Hemoglobin, primaryOutcomes measure: Changes in Hematocrit, primaryOutcomes measure: Changes in Plateletcrit, primaryOutcomes measure: Red cell Distribution Width Coefficient of Variation, primaryOutcomes measure: Changes in Particulate Matter Sizes, primaryOutcomes measure: Changes in Total Lipid Quantities, primaryOutcomes measure: Changes in Apolipoproteina, primaryOutcomes measure: Changes in Lipoprotein (a), secondaryOutcomes measure: Blood Pressure Changes, secondaryOutcomes measure: Heart Rate Changes, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Residential Address, city: Chongqing, state: Chongqing, zip: 402762, country: China, geoPoint lat: 29.56278, lon: 106.55278, documentSection largeDocumentModule largeDocs typeAbbrev: Prot_ICF, hasProtocol: True, hasSap: False, hasIcf: True, label: Study Protocol and Informed Consent Form, date: 2024-03-07, uploadDate: 2024-03-15T00:02, filename: Prot_ICF_000.pdf, size: 479591, hasResults: False
protocolSection identificationModule nctId: NCT06357078, orgStudyIdInfo id: AmasyaU-NU-679, briefTitle: Art Therapy and Caregivers Stress, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-02, primaryCompletionDateStruct date: 2024-06-28, completionDateStruct date: 2024-07-31, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-16, sponsorCollaboratorsModule leadSponsor name: Amasya University, class: OTHER, descriptionModule briefSummary: This research will be conducted to determine the effect of art therapy on the stress, anxiety and well-being of caregivers in the palliative care service., conditionsModule conditions: Caregiver Stress Syndrome, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: NONE, enrollmentInfo count: 52, type: ESTIMATED, armsInterventionsModule interventions name: Art Therapy, outcomesModule primaryOutcomes measure: Distress Thermometer, primaryOutcomes measure: The State Anxiety Inventory, primaryOutcomes measure: Personal Well-Being Index, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Neşe Uysal, status: RECRUITING, city: Amasya, zip: 0500, country: Turkey, contacts name: Neşe Uysal, role: CONTACT, phone: (90)3582181767, email: uysaln2007@hotmail.com, geoPoint lat: 40.65333, lon: 35.83306, hasResults: False
protocolSection identificationModule nctId: NCT06357052, orgStudyIdInfo id: 2701, briefTitle: The Study of Lithogenesis Processes in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), acronym: LINA, statusModule overallStatus: COMPLETED, startDateStruct date: 2019-07-19, primaryCompletionDateStruct date: 2022-04-30, completionDateStruct date: 2022-11-30, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Fondazione Policlinico Universitario Agostino Gemelli IRCCS, class: OTHER, descriptionModule briefSummary: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease, ranging from pure steatosis to non-alcoholic steatohepatitis and ultimately to liver cirrhosis. In order to study the association between NAFLD and nephrolithiasis while minimizing the confounding effect of metabolic syndrome, we investigated the impact of different degrees of NAFLD severity on potential risk factors for stone formation., conditionsModule conditions: NAFLD, conditions: Urinary Lithiasis, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 42, type: ACTUAL, armsInterventionsModule, outcomesModule primaryOutcomes measure: the analysis of the correlation between the degree of severity of NAFLD And urinary lithogenic profilecharacterized by reduced urinary magnesium and altered urinary ammonium excretion., eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Fondazione Policlinico A.Gemelli IRCCS, city: Roma, zip: 00168, country: Italy, geoPoint lat: 41.89193, lon: 12.51133, hasResults: False
protocolSection identificationModule nctId: NCT06357039, orgStudyIdInfo id: 09.2023.422, secondaryIdInfos id: 2220124, type: OTHER_GRANT, domain: Scientific and Technological Research Council of Türkiye (TÜBİTAK), secondaryIdInfos id: 1065371, type: OTHER_GRANT, domain: Small and Medium Enterprises Development Organization (KOSGEB), briefTitle: Validation Study of Sleep Tracking Devices, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-03-21, primaryCompletionDateStruct date: 2023-05-31, completionDateStruct date: 2023-07-17, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-25, sponsorCollaboratorsModule leadSponsor name: PNAPS Health Informatics and Space Technologies Inc., class: OTHER, collaborators name: Analog Devices, descriptionModule briefSummary: In this study, a two-part recursive convolutional neural networks model was developed, extracting features for each epoch window independently from before and after sleep onset (epoch encoder), and then trained in the context of long-term relationships in the sleep process (sequence encoder), using an approach similar to human expert classification based on information from single-channel forehead EEG and PPG (IR, Green, Red). The classification is based on guidelines from the American Academy of Sleep Medicine and calculated six parameters: total sleep duration (TST), wake (W), N1, N2, N3, and REM.The validation study of the developed model and the device was conducted at the Sleep Disorders Centre of the Istanbul Medical Faculty using concurrent polysomnographic data from 305 male and female patients aged 18 to 65 years., conditionsModule conditions: Sleep, conditions: Sleep Disorder, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 305, type: ACTUAL, armsInterventionsModule interventions name: Sleep tracking device, outcomesModule primaryOutcomes measure: Sleep Stages Classification Accuracy, primaryOutcomes measure: Interoception analysis from PPG data collected from facial skin, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Pnaps Health Informatics and Space Technologies Inc, city: Istanbul, state: Başıbüyük, Maltepe, zip: 34854, country: Turkey, geoPoint lat: 41.01384, lon: 28.94966, documentSection largeDocumentModule largeDocs typeAbbrev: Prot, hasProtocol: True, hasSap: False, hasIcf: False, label: Study Protocol, date: 2023-03-09, uploadDate: 2024-04-04T08:32, filename: Prot_000.pdf, size: 55944, largeDocs typeAbbrev: ICF, hasProtocol: False, hasSap: False, hasIcf: True, label: Informed Consent Form, date: 2023-03-09, uploadDate: 2024-04-04T04:55, filename: ICF_001.pdf, size: 78393, hasResults: False
protocolSection identificationModule nctId: NCT06357013, orgStudyIdInfo id: 2023-40, briefTitle: Postoperative Analgesia in Bilateral Knee Arthroplasties, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2024-01-01, primaryCompletionDateStruct date: 2024-05-01, completionDateStruct date: 2024-05-30, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Kocaeli City Hospital, class: OTHER_GOV, descriptionModule briefSummary: To observationally compare the analgesic efficacy of LIA and S-FICB techniques and to record the pain scores of patients who underwent bilateral knee operations in the postoperative period., conditionsModule conditions: Knee Arthroplasty, Total, conditions: Peripheral Nerve Block, conditions: Pain, Postoperative, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: Bilateral Suprainguinal fascia iliaca compartment block, interventions name: Local infiltration analgesia, outcomesModule primaryOutcomes measure: Suprainguinal fascia iliaca compartment block (S-FICB) produces adequate analgesic effect in knee arthroplasty., eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Kocaeli City Hospital, city: Kocaeli, country: Turkey, geoPoint lat: 39.62497, lon: 27.51145, hasResults: False
protocolSection identificationModule nctId: NCT06357000, orgStudyIdInfo id: Time from PCI to surgery, briefTitle: Time From PCI to Cancer Surgery and Cardiovascular and Oncologic Outcomes, statusModule overallStatus: COMPLETED, startDateStruct date: 2008-01-01, primaryCompletionDateStruct date: 2018-12-31, completionDateStruct date: 2018-12-31, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Samsung Medical Center, class: OTHER, descriptionModule briefSummary: To evaluate the association between time from PCI to cancer surgery and cardiovascular and oncologic outcomes in early-stage cancer patients, A retrospective, population-based cohort study was conducted using data from the Korean National Health Insurance Service (K-NHIS) database., conditionsModule conditions: Coronary Artery Disease, conditions: Cancer, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 3621, type: ACTUAL, armsInterventionsModule, outcomesModule primaryOutcomes measure: Occurence of Bleeding, secondaryOutcomes measure: Occurence of Spontaneous myocardial infarction, secondaryOutcomes measure: Occurence of Repeat revascularization, secondaryOutcomes measure: Occurence of Cancer recurrence, secondaryOutcomes measure: Occurence of All cause death, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06356987, orgStudyIdInfo id: 0002, briefTitle: Comparison of Laparoscopic Herniotomy and Open Herniotomy in Children, acronym: Herniotomy, statusModule overallStatus: COMPLETED, startDateStruct date: 2021-06-01, primaryCompletionDateStruct date: 2021-12-31, completionDateStruct date: 2021-12-31, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-12, sponsorCollaboratorsModule leadSponsor name: King Edward Medical University, class: OTHER, descriptionModule briefSummary: All patients of age 6 month to 12 years with inguinal hernia were included in study.Data was collected on detailed proforma regarding age, sex, side ,operative time, cosmesis, and postoperative complications, conditionsModule conditions: Inguinal Hernia, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: 66 patients with inguinal hernia were randomly divided into two groups (A and B), primaryPurpose: TREATMENT, maskingInfo masking: NONE, maskingDescription: 66 patients (33 patients in each group) of laparoscopic extraperitoneal closure and open herniotomy each, enrollmentInfo count: 66, type: ACTUAL, armsInterventionsModule interventions name: Herniotomy, outcomesModule primaryOutcomes measure: Operative time, primaryOutcomes measure: Recurrence, eligibilityModule sex: ALL, minimumAge: 6 Months, maximumAge: 12 Years, stdAges: CHILD, contactsLocationsModule locations facility: Muhammad Sharif, city: Lahore, state: Punjab, zip: 53711, country: Pakistan, geoPoint lat: 31.558, lon: 74.35071, hasResults: False
protocolSection identificationModule nctId: NCT06356974, orgStudyIdInfo id: STROgHAT, briefTitle: Stop Transmission of Gambiense Human African Trypanosomiasis (STROgHAT), acronym: STROgHAT, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-08, primaryCompletionDateStruct date: 2026-12-30, completionDateStruct date: 2027-12-30, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Drugs for Neglected Diseases, class: OTHER, collaborators name: Institute of Tropical Medicine, Belgium, collaborators name: Institut de Recherche pour le Developpement, collaborators name: Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo, collaborators name: Ministry of Public Health, Democratic Republic of the Congo, descriptionModule briefSummary: This protocol describes both the epidemiological study which aims at assessing whether over a three-year period a zero prevalence can be achieved when implementing a screen \& treat approach with acoziborole, as well as a nested clinical study aimed at generating further evidence on safety of acoziborole in gambiense human African trypanosomiasis (gHAT) seropositives individuals. The overall coordinator will be ITM. ITM will be fully responsible for the epidemiological study (study Part A), including cost effectiveness and evaluation of diagnostic tests. DNDi will be the legal sponsor of the nested safety clinical study (study Part B) and will ensure compliance with regulatory requirements and good clinical practices (GCP) for this part of the study.The investigators hypothesize that by systematically screening the populations of all endemic villages in a well-defined HAT focus and by expanding gHAT treatment to all seropositives, that it will be able to arrive at a zero prevalence over a three-year period.The objectives are to evaluate whether a strategy based on widened treatment for all parasitologically negative seropositive gHAT suspects with acoziborole can lead to interruption of transmission of T.b.gambiense in a mainland focus and to assess the safety of acoziborole in gHAT seropositve individuals and parasitologically negative., conditionsModule conditions: Human African Trypanosomiasis, designModule studyType: INTERVENTIONAL, phases: PHASE3, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: one-arm, open label, non-randomized, multicentre, phase IIIb study, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 2500, type: ESTIMATED, armsInterventionsModule interventions name: Treatment of seropositive individuals (positive serology test, but parasitology not confirmed), outcomesModule primaryOutcomes measure: Interruption of transmission of T.b. gambiense, primaryOutcomes measure: Assessment of safety, secondaryOutcomes measure: Economic evaluation, secondaryOutcomes measure: assessment of the performance of several diagnostic tests, eligibilityModule sex: ALL, minimumAge: 11 Years, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06356948, orgStudyIdInfo id: H23-02918, briefTitle: Rate of Tranexamic Acid Administration on Blood Pressure (RateTXA) Study., acronym: RateTXA, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-30, primaryCompletionDateStruct date: 2027-07-30, completionDateStruct date: 2027-12-30, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: University of British Columbia, class: OTHER, descriptionModule briefSummary: Tranexamic acid is a well-established treatment for post-partum hemorrhage. This study aims to examine the effect of tranexamic acid administration rates on blood pressure changes over 1 minute compared to 10 minutes in healthy pregnant patients scheduled for cesarean delivery., conditionsModule conditions: Healthy Participants, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: prospective, randomized, double-blind, non-inferiority trial.Arm 1: Intravenous infusion of TXA 1g (10 mL) administered over 1 minute. Arm 2: Intravenous infusion of TXA 1g (10 mL) administered over 10 minutes, primaryPurpose: PREVENTION, maskingInfo masking: TRIPLE, maskingDescription: An anesthesiologist or anesthesia assistant not involved in the study will draw up TXA and labelling them based on the randomization., whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, enrollmentInfo count: 110, type: ESTIMATED, armsInterventionsModule interventions name: Tranexamic Acid (TXA), outcomesModule primaryOutcomes measure: Change in systolic blood pressure from baseline over 15 minutes post-TXA administration between groups., secondaryOutcomes measure: Incidence of nausea, secondaryOutcomes measure: Incidence of vomiting, secondaryOutcomes measure: Incidence of hypotension, secondaryOutcomes measure: Incidence of hypertension, secondaryOutcomes measure: Incidence of central nervous system side effects, eligibilityModule sex: FEMALE, minimumAge: 19 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: BC Women's Hospital, status: RECRUITING, city: Vancouver, state: British Columbia, zip: V6H3N1, country: Canada, contacts name: Aislynn Sharrock, BA (Hons.), role: CONTACT, phone: 604-875-2158, phoneExt: 6335, email: aislynn.sharrock@cw.bc.ca, contacts name: Anton Chau, MD MMSc, role: PRINCIPAL_INVESTIGATOR, contacts name: Simon Wydall, MBBS MSc, role: SUB_INVESTIGATOR, contacts name: Juliana Barrera, MD MSc, role: SUB_INVESTIGATOR, geoPoint lat: 49.24966, lon: -123.11934, hasResults: False
protocolSection identificationModule nctId: NCT06356935, orgStudyIdInfo id: HP2024, briefTitle: Effects of Heavy-load Resistance Training, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-03-17, primaryCompletionDateStruct date: 2023-08-03, completionDateStruct date: 2023-08-03, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: University of Southern Denmark, class: OTHER, collaborators name: Team Denmark, descriptionModule briefSummary: The study aims to investigate effects of 8-weeks of heavy-load resistance training on mechanical muscle function and functional performance in elite female team handball players from the Danish Women's Handball League. Players will be randomly assigned to either a resistance training group (RT) or serves as training-as-usual controls (CON)., conditionsModule conditions: Healthy, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Randomized controlled trial, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 60, type: ACTUAL, armsInterventionsModule interventions name: RT, interventions name: CON, outcomesModule primaryOutcomes measure: Explosive muscle strength, primaryOutcomes measure: Acceleration capacity, primaryOutcomes measure: Agility performance, primaryOutcomes measure: Jump ability, eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 35 Years, stdAges: ADULT, contactsLocationsModule locations facility: University of Southern Denmark, city: Odense, zip: 5230, country: Denmark, geoPoint lat: 55.39594, lon: 10.38831, hasResults: False
protocolSection identificationModule nctId: NCT06356909, orgStudyIdInfo id: SUPREMEneo, briefTitle: Study of PREMEdication Before Laryngoscopy in Neonates in France, acronym: SUPREMEneo, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-11, primaryCompletionDateStruct date: 2024-04-07, completionDateStruct date: 2024-04-07, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Centre Hospitalier Intercommunal Creteil, class: OTHER, descriptionModule briefSummary: This study is a national prospective survey on practices of premedication before laryngoscopy in neonates. The survey will evaluate adequation to the French best practice guidelines to improve their dissemination and to identify current practices of premedication before laryngoscopy in neonates in French units (agents, dosing, efficacy, safety), conditionsModule conditions: Neonatal Respiratory Distress, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 900, type: ESTIMATED, armsInterventionsModule interventions name: Survey of sedo-analgesia practices before laryngoscopy, outcomesModule primaryOutcomes measure: Proportion of patients who received a 1st sequence of sedo-analgesia consistent with best practice guidelines during laryngoscopy or laryngeal mask placement, secondaryOutcomes measure: Molecules used for sedo-analgesia, secondaryOutcomes measure: Cumulative doses of sedo-analgesia used, secondaryOutcomes measure: Questionnaire for the operator describing reasons for non-compliance with best practice guidelines, secondaryOutcomes measure: Numeric rating scale for pain (by operator and assistant), secondaryOutcomes measure: TRACHEA score (Tonus, Reactivity, Awareness & Conditions of intubation to Help in Endotracheal intubation Assessment), secondaryOutcomes measure: Side effects related to the premedication, eligibilityModule sex: ALL, minimumAge: 20 Weeks, maximumAge: 44 Weeks, stdAges: CHILD, contactsLocationsModule locations facility: Centre Hospitalier Intercommunal de Creteil, status: RECRUITING, city: Creteil, zip: 94000, country: France, contacts name: Manon TAUZIN, MD, role: CONTACT, phone: 0157023458, email: manon.tauzin@chicreteil.fr, geoPoint lat: 48.78333, lon: 2.46667, hasResults: False